Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 819-823

  Magyarosy, E ^a   Sebestypen A ^a   Timar J ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

ALL; CD44v6; NM23 H1; Risk groups

Indexed keywords

CD44V ANTIGEN; EPITOPE; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN CD44V6; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPHOID CELL; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOLID TUMOR; TREATMENT OUTCOME;

ANTIGENS, CD44; BONE MARROW; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GLYCOPROTEINS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PHENOTYPE; PROGNOSIS; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0035065147     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. CD44 splice variants confer metastatic behaviour in rats: Homologous sequences are expressed in human tumor cell lines
2. Evidence for a novel gene associated with low tumor metastatic potential
3. Clinical implications of anomalous CD44 gene expression in neoplasia
4. Nm23 and tumour metastasis: Basic and translational advances
5. Homing receptors and the control of lymphocyte migration
6. Serum CD44 in non-Hodgkin's lymphoma
7. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy
8. A strong expression of CD44v6 correlates with shorter survival of patients with acute myeloid leukemia
9. Serum soluble CD44 in pediatric patients with acute leukemia
10. Search for genes that suppress cancer metastasis
11. Alteration of Nm23 gene expression during the induced differentiation of human leukemia cell lines
12. NM23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia
13. Evaluation by multivariate analysis of the differentiation inhibitory factor Nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies
14. Proposals for the immunological classification of acute leukaemias. European Group For the Immunological Characterization of leukaemias /EGIL/
15. Flow cytometric analysis of cell-surface and intracellular antigens in leukaemia diagnosis
16. Participation in normal immune response of a metastasis-inducing splice variant of CD44